{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:55:23Z","timestamp":1794570923514,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Bloodstream infection caused by\n                      <jats:italic toggle=\"yes\">Acinetobacter baumannii<\/jats:italic>\n                      has become a major clinical concern, especially multidrug-resistant\n                      <jats:italic toggle=\"yes\">A baumannii<\/jats:italic>\n                      (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality of patients with MDRAB bacteremia. Patients with nosocomial acquired\n                      <jats:italic toggle=\"yes\">A baumannii<\/jats:italic>\n                      bacteremia were enrolled between January, 2013 and December, 2017 at the First Affiliated Hospital, School of Medicine, Zhejiang University. Medical records were reviewed, and the clinical and microbial characteristics were collected. Among the 338 patients suffering from\n                      <jats:italic toggle=\"yes\">A baumannii<\/jats:italic>\n                      bacteremia, 274 patients were infected with MDRAB bacteremia. Bacteremia-related mortality was 46.4% for the overall sample; 56.2% for MDRAB bacteremia patients, 4.7% for non-MDRAB bacteremia patients. The identified risk factors for developing MDRAB bacteremia were previous exposure to carbapenems [odds ratio (OR) 5.78,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.005] and penicillins+\u03b2-lactamase inhibitors (OR 4.29,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.009). Primary bacteremia tended to develop non-MDR bacteremia (OR 0.10,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.002). The risk factors for MDRAB bacteremia-related mortality were old age (OR 1.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.036), a high Pitt bacteremia score (OR 1.32,\n                      <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>\n                      &lt;\n                      <jats:italic toggle=\"yes\">\u200a<\/jats:italic>\n                      .001), bacteremia occurring after severe pneumonia (OR 8.66,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&lt;\u200a.001), while catheter-related infection (OR 0.47,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.049) and operations for treating infection (OR 0.51,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.043) may have a better outcome. Patients with MDRAB had a higher mortality rate. Patients with previous carbapenems and penicillins+\u03b2-lactamase inhibitor exposure are at an increased risk of MDRAB bacteremia, whereas patients with primary bacteremia tended to develop non-MDR bacteremia. The risk factors for MDRAB bacteremia-related mortality were old age, a high Pitt bacteremia score, and bacteremia occurring after severe pneumonia, whereas catheter-related infection and operations for the treatment of infection may have a better outcome.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000014937","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T14:57:14Z","timestamp":1553785034000},"page":"e14937","source":"Crossref","is-referenced-by-count":81,"title":["Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia"],"prefix":"10.1097","volume":"98","author":[{"given":"Hua","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Respiratory Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yake","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingquan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Child Health Care, Zhejiang University Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hangzhou Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Lab for Diagnostic and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital of College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment","volume":"54","author":"Smolyakov","year":"2003","journal-title":"J Hosp Infect"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.ajic.2015.11.019","article-title":"Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China","volume":"44","author":"Guo","year":"2016","journal-title":"Am J Infect Control"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","article-title":"Epidemiology of antimicrobial resistance in bloodstream infections","volume":"7","author":"Akova","year":"2016","journal-title":"Virulence"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/14656561003596350","article-title":"Treatment of Acinetobacter infections","volume":"11","author":"Michalopoulos","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502091","article-title":"Completely resistant Acinetobacter baumannii strains","volume":"23","author":"Mahgoub","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/fmb-2016-0158","article-title":"Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting","volume":"12","author":"Marchaim","year":"2017","journal-title":"Future Microbiol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3201\/eid1301.060716","article-title":"Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization","volume":"13","author":"Sunenshine","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/CCM.0000000000000125","article-title":"Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients","volume":"42","author":"Lee","year":"2014","journal-title":"Crit Care Med"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jmii.2014.10.006","article-title":"Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e0130701","DOI":"10.1371\/journal.pone.0130701","article-title":"Risk and prognostic factors for multidrug-resistant Acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of west China","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"key":"R11-20230914","first-page":"118","article-title":"Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study","volume":"41","author":"Shih","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"e2943","DOI":"10.1097\/MD.0000000000002943","article-title":"Risk factors and clinical outcomes for patients with Acinetobacter baumannii bacteremia","volume":"95","author":"Gu","year":"2016","journal-title":"Medicine"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"O1028","DOI":"10.1111\/1469-0691.12716","article-title":"A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia","volume":"20","author":"Nutman","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jmii.2015.01.003","article-title":"Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis","volume":"50","author":"Liu","year":"2017","journal-title":"J Microbiol Immunologyd Infect"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/cid\/cis385","article-title":"Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection","volume":"55","author":"Lee","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11908-009-0050-2","article-title":"Severe hospital-acquired pneumonia: a review for clinicians","volume":"11","author":"Dallas","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000356004","article-title":"Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"59","author":"Garnacho-Montero","year":"2013","journal-title":"Chemotherapy"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/AAC.00984-16","article-title":"Clinical features and risk factors for development of breakthrough gram-negative bacteremia during carbapenem therapy","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"e25298","DOI":"10.1371\/journal.pone.0025298","article-title":"Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients","volume":"6","author":"Eber","year":"2011","journal-title":"PloS One"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1086\/592698","article-title":"Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients","volume":"29","author":"Perencevich","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"(suppl 2)","key":"R27-20230914","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)","volume":"32 suppl 2","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/313441","article-title":"Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System","volume":"29","author":"McDonald","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1469-0691.2012.03954.x","article-title":"Seasonality in Gram-negative and healthcare-associated infections","volume":"18","author":"Richet","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/517954","article-title":"Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia","volume":"28","author":"Lee","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1086\/508360","article-title":"Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality","volume":"43","author":"Gkrania-Klotsas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhin.2006.04.015","article-title":"Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature","volume":"64","author":"Falagas","year":"2006","journal-title":"J Hosp Infect"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1128\/AAC.02441-14","article-title":"Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex","volume":"58","author":"Chopra","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"(suppl 2)","key":"R34-20230914","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1086\/504481","article-title":"Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli","volume":"43","author":"Donskey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2009.06.007","article-title":"Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study","volume":"73","author":"Jang","year":"2009","journal-title":"J Hosp Infect"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejim.2009.05.005","article-title":"Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia","volume":"20","author":"Metan","year":"2009","journal-title":"Eur J Intern Med"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jac\/dkl130","article-title":"Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/clinids\/22.6.1026","article-title":"Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features","volume":"22","author":"Cisneros","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R39-20230914","first-page":"242","article-title":"[Acinetobacter baumannii bacteremia: clinical and prognostic features]","volume":"21","author":"Rodriguez-Bano","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/674387","article-title":"A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia","volume":"35","author":"Ng","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-008-0473-y","article-title":"Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance","volume":"27","author":"Wareham","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clinthera.2011.11.028","article-title":"Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009","volume":"34","author":"Morfin-Otero","year":"2012","journal-title":"Clin Ther"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ja.2013.84","article-title":"In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii","volume":"66","author":"Ni","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1179\/1973947812Y.0000000029","article-title":"In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates","volume":"24","author":"Deveci","year":"2012","journal-title":"J Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903290-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:23:50Z","timestamp":1694708630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903290-00017"}},"subtitle":["A retrospective study from a Chinese hospital"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014937","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}